CMC Berkshires (Center for Motivation and Change)

CMC Berkshires (Center for Motivation and Change) is a SAMHSA-registered addiction-treatment facility located at Wichita, KS. The specific care levels offered by CMC Berkshires (Center for Motivation and Change) should be confirmed directly with the admissions team. Patient-level evaluation of this facility should distinguish three considerations: state licensure status, voluntary accreditation (CARF or Joint Commission), and clinical-framework alignment with current ASAM Criteria — each of which is independently verifiable.

Care levels at CMC Berkshires (Center for Motivation and Change)

Care-level specifics for CMC Berkshires (Center for Motivation and Change) are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. ASAM Criteria 4e level-of-care matching requires clinical assessment across six dimensions (withdrawal potential, biomedical conditions, emotional/behavioral/cognitive conditions, readiness, relapse risk, recovery environment). The alignment of CMC Berkshires (Center for Motivation and Change)'s offerings to any specific patient's clinical profile should be determined by an independent ASAM-aligned assessment prior to admission.

Insurance and payment

Payment and insurance specifics for CMC Berkshires (Center for Motivation and Change) are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The operational prerequisite for admission is written documentation of: (a) network contract status; (b) prior authorization; (c) cost-sharing structure; (d) medical-necessity criteria applied. Absence of any of these four increases the probability of post-admission financial disagreement.

Before you call

Pre-admission due-diligence for CMC Berkshires (Center for Motivation and Change): (1) ASAM 4e level-of-care documentation matching clinical assessment; (2) written Verification of Benefits specific to insurance product; (3) MAT policy documentation (particularly buprenorphine and methadone continuation protocols for opioid use disorder patients); (4) accreditation verification via CARF or Joint Commission provider-search tools; (5) state licensing status confirmed via KS behavioral-health regulator inspection records. If the clinical situation involves opioid use disorder, confirm explicitly whether CMC Berkshires (Center for Motivation and Change) offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.